10 results on '"Gyssens, Ic"'
Search Results
2. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.
- Author
-
Averbuch D, Orasch C, Cordonnier C, Livermore DM, Mikulska M, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, and Akova M
- Subjects
- Anti-Bacterial Agents pharmacology, Drug Resistance, Bacterial drug effects, Europe epidemiology, Fever epidemiology, Fever microbiology, Humans, Leukemia epidemiology, Leukemia microbiology, Neutropenia epidemiology, Neutropenia microbiology, Anti-Bacterial Agents therapeutic use, Drug Resistance, Bacterial physiology, Fever drug therapy, Leukemia drug therapy, Neutropenia drug therapy, Practice Guidelines as Topic standards
- Abstract
Owing to increasing resistance and the limited arsenal of new antibiotics, especially against Gram-negative pathogens, carefully designed antibiotic regimens are obligatory for febrile neutropenic patients, along with effective infection control. The Expert Group of the 4(th) European Conference on Infections in Leukemia has developed guidelines for initial empirical therapy in febrile neutropenic patients, based on: i) the local resistance epidemiology; and ii) the patient's risk factors for resistant bacteria and for a complicated clinical course. An 'escalation' approach, avoiding empirical carbapenems and combinations, should be employed in patients without particular risk factors. A 'de-escalation' approach, with initial broad-spectrum antibiotics or combinations, should be used only in those patients with: i) known prior colonization or infection with resistant pathogens; or ii) complicated presentation; or iii) in centers where resistant pathogens are prevalent at the onset of febrile neutropenia. In the latter case, infection control and antibiotic stewardship also need urgent review. Modification of the initial regimen at 72-96 h should be based on the patient's clinical course and the microbiological results. Discontinuation of antibiotics after 72 h or later should be considered in neutropenic patients with fever of unknown origin who are hemodynamically stable since presentation and afebrile for at least 48 h, irrespective of neutrophil count and expected duration of neutropenia. This strategy aims to minimize the collateral damage associated with antibiotic overuse, and the further selection of resistance.
- Published
- 2013
- Full Text
- View/download PDF
3. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).
- Author
-
Averbuch D, Cordonnier C, Livermore DM, Mikulska M, Orasch C, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, and Akova M
- Subjects
- Drug Resistance, Multiple, Bacterial physiology, Europe epidemiology, Gram-Negative Bacterial Infections drug therapy, Gram-Negative Bacterial Infections microbiology, Gram-Positive Bacterial Infections drug therapy, Gram-Positive Bacterial Infections microbiology, Humans, Leukemia epidemiology, Leukemia microbiology, Anti-Bacterial Agents administration & dosage, Drug Delivery Systems methods, Drug Resistance, Multiple, Bacterial drug effects, Hematopoietic Stem Cell Transplantation adverse effects, Leukemia drug therapy, Practice Guidelines as Topic standards
- Abstract
The detection of multi-resistant bacterial pathogens, particularly those to carbapenemases, in leukemic and stem cell transplant patients forces the use of old or non-conventional agents as the only remaining treatment options. These include colistin/polymyxin B, tigecycline, fosfomycin and various anti-gram-positive agents. Data on the use of these agents in leukemic patients are scanty, with only linezolid subjected to formal trials. The Expert Group of the 4(th) European Conference on Infections in Leukemia has developed guidelines for their use in these patient populations. Targeted therapy should be based on (i) in vitro susceptibility data, (ii) knowledge of the best treatment option against the particular species or phenotype of bacteria, (iii) pharmacokinetic/pharmacodynamic data, and (iv) careful assessment of the risk-benefit balance. For infections due to resistant Gram-negative bacteria, these agents should be preferably used in combination with other agents that remain active in vitro, because of suboptimal efficacy (e.g., tigecycline) and the risk of emergent resistance (e.g., fosfomycin). The paucity of new antibacterial drugs in the near future should lead us to limit the use of these drugs to situations where no alternative exists.
- Published
- 2013
- Full Text
- View/download PDF
4. Navigating the Web in search of resources on antimicrobial stewardship in health care institutions.
- Author
-
Pagani L, Gyssens IC, Huttner B, Nathwani D, and Harbarth S
- Subjects
- Health Resources, Humans, Internet, Anti-Bacterial Agents therapeutic use, Bacterial Infections drug therapy, Cross Infection drug therapy, Medication Therapy Management, Practice Guidelines as Topic
- Abstract
Bacterial resistance to antimicrobials has become a public health threat for which coordinated action at the international, national, and local level is needed. Current recommendations for the control of antimicrobial overuse and resistance in hospitals recommend various strategies, including antimicrobial stewardship programs. Several of these integrated and multidisciplinary antimicrobial management programs provide detailed information and recommendations on the Web. We performed a search of the most relevant and authoritative Web sites in English that were available without need for special registration or cost. The search excluded community-based programs, and we present only established programs or those providing expert information useful for building a hospital-based antimicrobial stewardship program. The overview of these Web sites may be useful either for institutions or individuals planning to implement such programs in their own health care institution or for educational purposes targeted at different professionals involved in improving antimicrobial practice.
- Published
- 2009
- Full Text
- View/download PDF
5. Experiences with the Dutch Working Party on antibiotic policy (SWAB).
- Author
-
Prins JM, Degener JE, de Neeling AJ, and Gyssens IC
- Subjects
- Evidence-Based Medicine, Hospitalization, Humans, Netherlands, Treatment Outcome, Anti-Bacterial Agents therapeutic use, Bacterial Infections drug therapy, Cross Infection prevention & control, Drug Resistance, Bacterial, Health Policy trends, Practice Guidelines as Topic
- Abstract
The Dutch Working Party on Antibiotic Policy (Stichting Werkgroep AntibioticaBeleid, SWAB) was founded in 1996 as an initiative of the Society for Infectious Diseases, the Dutch Society for Medical Microbiology, and the Dutch Association of Hospital Pharmacists. Its primary goal is to contribute to the containment of antimicrobial resistance and the expanding costs incurred for the use of antibiotics. SWAB is the Intersectoral Coordinating Mechanism (ICM) for the Netherlands, and it is at present the National Antimicrobial Resistance (AMR) Focal Point. It coordinates the national surveillance of antibiotic resistance, in collaboration with the National Institute for Public Health and the Environment(RIVM), coordinates the surveillance of the use of antibiotics,and runs a guideline development programme. Information about consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria is presented annually in NethMap. Over the past decade, outpatient consumption of antibiotics has risen only slightly, but in the hospital setting there was an overall significant increase in antibiotic use, due mainly to the steady reduction in the average length of patient hospital stays. In 2006 we introduced our electronic national antibiotic guide 'SWAB-ID' for the antibiotic treatment and prophylaxis of common infectious diseases in hospitals.
- Published
- 2008
6. Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis.
- Author
-
van Kasteren ME, Mannien J, Kullberg BJ, de Boer AS, Nagelkerke NJ, Ridderhof M, Wille JC, and Gyssens IC
- Subjects
- Anti-Bacterial Agents economics, Anti-Bacterial Agents therapeutic use, Antibiotic Prophylaxis economics, Antibiotic Prophylaxis standards, Cross Infection epidemiology, Health Care Surveys, Humans, Incidence, Netherlands epidemiology, Prospective Studies, Surgical Wound Infection epidemiology, Anti-Bacterial Agents administration & dosage, Antibiotic Prophylaxis statistics & numerical data, Cross Infection prevention & control, Drug Utilization Review statistics & numerical data, Hospitals standards, Practice Guidelines as Topic, Surgical Wound Infection prevention & control, Total Quality Management
- Abstract
Objectives: Misuse of antibiotics in surgical prophylaxis is still quite common. The objectives of this study were to reduce the quantity and improve the quality of surgical prophylaxis and to reduce costs., Methods: Prospective multi-site study of elective procedures in 13 Dutch hospitals. The quality of prophylaxis was audited before and after an intervention consisting of performance feedback and implementation of national clinical practice guidelines. Process outcome parameters were antibiotic choice, duration, timing, antibiotic volume and costs. Segmented regression analysis was used to estimate the effect size of the intervention. Patient outcome was documented by the incidence of surgical site infections (SSI)., Results: Before the intervention, 1763 procedures were recorded and 2050 thereafter. Antimicrobial use decreased from 121 to 79 DDD (defined daily doses)/100 procedures and costs reduced by 25% per procedure. After the intervention, antibiotic choice was inappropriate in only 37.5% of the cases instead of in 93.5% expected cases had the intervention not occurred. Prolonged prophylaxis was observed in 31.4% instead of 46.8% expected cases and inappropriate timing in 39.4% instead of the expected 51.8%. Time series analysis showed that all improvements were statistically significant (P < 0.01) and that they could be fully attributed to the intervention. The overall SSI rates before and after intervention were 5.4% (95% CI: 4.3-6.5) and 4.6% (95% CI: 3.6-5.4), respectively., Conclusions: The intervention led to improved quality of surgical prophylaxis and to reduced antibiotic use and costs without impairment of patient outcome.
- Published
- 2005
- Full Text
- View/download PDF
7. National guidelines for the use of antibiotics in hospitalised adult patients: the SWAB guidelines revisited.
- Author
-
Prins JM, Kullberg BJ, and Gyssens IC
- Subjects
- Adult, Community-Acquired Infections drug therapy, Drug Resistance, Hospitalization, Humans, Netherlands, Pneumonia, Bacterial drug therapy, Societies, Medical, Societies, Pharmaceutical, Anti-Bacterial Agents therapeutic use, Evidence-Based Medicine, Practice Guidelines as Topic
- Abstract
Since 1996, the Dutch Working Party on Antibiotic Policy (Stichting Werkgroep AntibioticaBeleid, SWAB) has been developing national guidelines for the use of antibiotics in hospitalised adult patients. As a result of both an inventory of the wishes of the users of these guidelines and the recently developed criteria for evidence-based guideline development, we have revised our format for the development of SWAB guidelines. By involving the members of the relevant professional societies and giving them the opportunity to comment on the guidelines at an early stage, we are aiming for a successful implementation of the guidelines in the hospitals.
- Published
- 2005
8. International guidelines for infectious diseases: a practical guide.
- Author
-
Gyssens IC
- Subjects
- Community Health Services standards, Hospitals standards, Humans, Internationality, Netherlands, Societies, Medical, Societies, Pharmaceutical, Anti-Bacterial Agents therapeutic use, Communicable Disease Control standards, Infection Control standards, Practice Guidelines as Topic standards, Program Development
- Abstract
A growing number of organisations have become involved in the development of guidelines for infectious diseases (ID). The degree of acceptation of guidelines varies from one country to another. Some of these national differences are determining the practices of prescribing antibiotics, and infection control both in hospitals and in the community. This review provides updated information on ID guideline programmes, in particular on the topic of antimicrobial therapy. It is aimed at clinicians, both in their role as care providers and as designers of local antibiotic guidelines (antibiotic booklets). Definitions are given and the process of development is discussed. International and national ID guideline programmes in the English language are presented. Many URLs provide access to the different websites where most guidelines can be downloaded free of charge.
- Published
- 2005
9. Adherence to local hospital guidelines for surgical antimicrobial prophylaxis: a multicentre audit in Dutch hospitals.
- Author
-
van Kasteren ME, Kullberg BJ, de Boer AS, Mintjes-de Groot J, and Gyssens IC
- Subjects
- Adult, Aged, Aged, 80 and over, Antibiotic Prophylaxis methods, Antibiotic Prophylaxis statistics & numerical data, Female, Guideline Adherence statistics & numerical data, Hospitals standards, Hospitals statistics & numerical data, Humans, Male, Medical Audit methods, Medical Audit statistics & numerical data, Middle Aged, Netherlands, Prospective Studies, Surgery Department, Hospital statistics & numerical data, Antibiotic Prophylaxis standards, Guideline Adherence standards, Medical Audit standards, Practice Guidelines as Topic standards, Surgery Department, Hospital standards
- Abstract
Objective: To study the adherence to local hospital guidelines for antimicrobial prophylaxis in surgery, and explore reasons for non-adherence., Methods: A prospective, multicentre audit of elective procedures, without prior suspicion of infection, was carried out in 13 Dutch hospitals. By reviewing medical, anaesthetic and nursing records, and medication charts, the prescription of antibiotics was compared with the local hospital guideline on antibiotic choice, duration of prophylaxis, dose, dosing interval and timing of the first dose., Results: Between January 2000 and January 2001, 1763 procedures were studied. Antibiotic choice, duration, dose, dosing interval and timing of the first dose were concordant with the hospital guideline in 92%, 82%, 89%, 43% and 50%, respectively. Overall adherence to all aspects of the guideline, however, was achieved in only 28%. The most important barriers to local guideline adherence were lack of awareness due to ineffective distribution of the most recent version of the guidelines, lack of agreement by surgeons with the local hospital guidelines, and environmental factors, such as organizational constraints in the surgical suite and in the ward., Conclusion: This study shows that, although adherence to separate aspects of local hospital guidelines for surgical prophylaxis in the Netherlands is favourable, overall adherence to all parameters is hard to achieve. Adherence to guidelines on dosing interval and timing needs improvement, in particular. To increase the quality of antimicrobial prophylaxis in surgery, effort should be put into developing guidelines acceptable to surgeons, in adequately distributing the guidelines and to facilitating logistics. Audits of surgical prophylaxis may help hospitals identify barriers to guideline adherence.
- Published
- 2003
- Full Text
- View/download PDF
10. Quality indicators for responsible antibiotic use in the inpatient setting: a systematic review followed by an international multidisciplinary consensus procedure
- Author
-
Monnier, AA, Schouten, J, Le Maréchal, M, Tebano, G, Pulcini, C, Stanić Benić, M, Vlahović-Palĉevski, V, Milanič, R, Adriaenssens, N, Versporten, A, Huttner, B, Zanichelli, V, Hulscher, ME, Gyssens, IC, Antonisse, A, Beović, B, Borg, M, Buyle, F, Cavaleri, M, Dhillon, H, Dumartin, C, Drew, R, Findlay, D, Ghafur, A, Grayson, L, Hermsen, E, Hicks, L, Howard, P, Kenston, M, Kesselheim, AS, Knirsch, C, Lacor, P, Laxminarayan, R, Paul, M, Plachouras, D, Poulakou, G, Rabaud, C, Rex, JH, Rodriguez-Baño, J, Srinivasan, A, Lundborg, CS, Tängdén, T, Thamlikitkul, V, Waluszewski, A, Wellsteed, S, Wertheim, H, Wild, C, Maladies chroniques, santé perçue, et processus d'adaptation (APEMAC), Université de Lorraine (UL), Service des Maladies Infectieuses et Tropicales [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Department of Infectious Diseases and Infection Control [Geneva, Switzerland], Hôpitaux Universitaires de Genève (HUG), Scientific Center for Quality of Healthcare [Nijmegen, The Netherlands], Radboud University Medical Center [Nijmegen]-Radboud Institute for Health Sciences [Nijmegen, the Netherlands], University Medical Center Ljubljana, European Medicines Agency [London] (EMA), Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Center for Disease Dynamics, Economics & Policy (CDDEP), Sackler Faculty of Medicine, Tel Aviv University [Tel Aviv], Fourth Department of Medicine, University Hospital Virgen Macarena, Department of Economic History, Uppsala University, Oxford University Clinical Research Unit [Ho Chi Minh City] (OUCRU), Radboud University Medical Center [Nijmegen], Hasselt University (UHasselt), University Hospital Rijeka, University of Rijeka, Vaccine & Infectious Disease Institute [Antwerp, Belgium] (VAXINFECTIO), University of Antwerp (UA), Geneva University Hospitals and Geneva University, DRIVE-AB WP1 Grp, and APH - Aging & Later Life
- Subjects
0301 basic medicine ,Microbiology (medical) ,medicine.medical_specialty ,Internationality ,Delphi Technique ,intrinsic drive ,030106 microbiology ,lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4] ,BIOMEDICINE AND HEALTHCARE. Basic Medical Sciences. Pharmacology ,Medical Records ,antibiotics ,inpatients ,Antimicrobial Stewardship ,03 medical and health sciences ,Stakeholder Participation ,Surveys and Questionnaires ,Antimicrobial chemotherapy ,medicine ,Humans ,Pharmacology (medical) ,guidelines ,Antibiotic use ,internet ,quality indicators ,public health medicine ,community ,consensus ,Intensive care medicine ,Biology ,ComputingMilieux_MISCELLANEOUS ,Quality Indicators, Health Care ,Pharmacology ,ddc:616 ,Internet ,business.industry ,Pharmacology. Therapy ,BIOMEDICINA I ZDRAVSTVO. Temeljne medicinske znanosti. Farmakologija ,Anti-Bacterial Agents ,3. Good health ,lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4] ,Infectious Diseases ,Supplement Papers ,Practice Guidelines as Topic ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Public Health ,Human medicine ,business - Abstract
Contains fulltext : 193452.pdf (Publisher’s version ) (Open Access) Background: This study was conducted as part of the Driving Reinvestment in Research and Development and Responsible Antibiotic Use (DRIVE-AB) project and aimed to develop generic quality indicators (QIs) for responsible antibiotic use in the inpatient setting. Methods: A RAND-modified Delphi method was applied. First, QIs were identified by a systematic review. A complementary search was performed on web sites of relevant organizations. Duplicates were removed and disease and patient-specific QIs were combined into generic indicators. The relevance of these QIs was appraised by a multidisciplinary international stakeholder panel through two questionnaires and an in-between consensus meeting. Results: The systematic review retrieved 70 potential generic QIs. The QIs were appraised by 25 international stakeholders with diverse backgrounds (medical community, public health, patients, antibiotic research and development, regulators, governments). Ultimately, 51 QIs were selected in consensus. QIs with the highest relevance score included: (i) an antibiotic plan should be documented in the medical record at the start of the antibiotic treatment; (ii) the results of bacteriological susceptibility testing should be documented in the medical record; (iii) the local guidelines should correspond to the national guidelines but should be adapted based on local resistance patterns; (iv) an antibiotic stewardship programme should be in place at the healthcare facility; and (v) allergy status should be taken into account when antibiotics are prescribed. Conclusions: This systematic and stepwise method combining evidence from literature and stakeholder opinion led to multidisciplinary international consensus on generic inpatient QIs that can be used globally to assess the quality of antibiotic use.
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.